YOKOHAMA - As the risks of cancer increase among Japan's aging population, immunologist Tasuku Honjo is pinning his hopes on cancer treatments that shift the paradigm from traditional approaches directly targeting cancer cells to ones that stimulate the body's immune system to fight the disease.
Sorry. This article is no longer available.
Sorry, this article was first published more than three months ago and is temporarily unavailable.
Once the upcoming introduction of a paid membership system is fully operational, paid members will have access to all our stories.
Free Membership Provides
Newsletter from Editorial Team and access to archive articles from past three months.
By continuing, you agree to the Terms of Use,
and Privacy Policy.
